UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

The lancet oncology, 2016-08, Vol.17 (8), p.1047-1060

2016

Volltextzugriff (PDF)

A national dosimetry audit for stereotactic ablative radiotherapy in lung

Radiotherapy and oncology, 2017-03, Vol.122 (3), p.406-410

2017

Volltextzugriff (PDF)

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2016-08, Vol.95 (5), p.1367-1377

2016

Volltextzugriff (PDF)

Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial

Clinical and translational radiation oncology, 2020-03, Vol.21, p.77-84

2020

Volltextzugriff (PDF)

PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)

Clinical and translational radiation oncology, 2020-11, Vol.25, p.22-28

2020

Volltextzugriff (PDF)

1611: Effect of bladder volumes changes on bowel doses during prostate with pelvic lymph-node radiotherapy

Radiotherapy and oncology, 2024-05, Vol.194, p.S4047-S4049

2024

Volltextzugriff (PDF)

Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas

International journal of radiation oncology, biology, physics, 2005-10, Vol.63 (2), p.392-400

2005

Volltextzugriff (PDF)

Planning With Intensity-Modulated Radiotherapy and Tomotherapy to Modulate Dose Across Breast to Reflect Recurrence Risk (IMPORT High Trial)

International journal of radiation oncology, biology, physics, 2011-03, Vol.79 (4), p.1064-1072

2011

Volltextzugriff (PDF)

CTNI-70. RADIOTHERAPY QUALITY ASSURANCE IN THE ROAM/EORTC1308 ATYPICAL MENINGIOMA RANDOMISED CONTROLLED TRIAL: PROSPECTIVE REVIEW IMPROVES RADIOTHERAPY QUALITY AND CONSISTENCY

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v93-v93

2023

Volltextzugriff (PDF)

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

The Lancet (British edition), 2017-09, Vol.390 (10099), p.1048-1060

2017

Volltextzugriff (PDF)

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer

Radiotherapy and oncology, 2020-01, Vol.142, p.62-71

2020

Volltextzugriff (PDF)

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

International journal of radiation oncology, biology, physics, 2019-03, Vol.103 (3), p.605-617

2019

Volltextzugriff (PDF)

BIOPROP20: biologically optimised IMRT for prostate radiotherapy in 20 fractions. Hypofractionated radiotherapy with intraprostatic boosts to tumour nodules in men with intermediate- and high-risk prostate cancer: a phase II trial – five-year outcomes

Royal College of Radiologists Open, 2023-12, Vol.1, p.100023, Article 100023

2023

Volltextzugriff (PDF)

PIVOTALboost Trial contouring RTQA

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.373-373

2020

Volltextzugriff (PDF)

The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma

Brachytherapy, 2014, Vol.13 (1), p.1-14

2014

Volltextzugriff (PDF)

Pretrial outlining quality assurance in PIVITOLBoost

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.50-50

2019

Volltextzugriff (PDF)

Normal Tissue Complication Probability (NTCP) model for erectile dysfunction (ED) following external beam radiotherapy (RT) for prostate cancer

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.135-135

2018

Volltextzugriff (PDF)

Local tumor control after 106Ru brachytherapy of choroidal melanoma

International journal of radiation oncology, biology, physics, 2005-10, Vol.63 (2), p.385-391

2005

Volltextzugriff (PDF)

Local tumor control after {sup 106}Ru brachytherapy of choroidal melanoma

International journal of radiation oncology, biology, physics, 2005-10, Vol.63 (2)

2005

Volltextzugriff (PDF)

Forward and inverse-planned intensity-modulated radiotherapy (IMRT) in the CHHiP trial: A comparison of dosimetry and normal tissue toxicity

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.37-37

2014

Volltextzugriff (PDF)

Visual acuity after Ruthenium106 brachytherapy of choroidal melanomas

International journal of radiation oncology, biology, physics, 2005-10, Vol.63 (2), p.392-400

2005

Volltextzugriff (PDF)

Comparison of hypofractionated high-dose intensity-modulated radiotherapy schedules for prostate cancer: Results from the phase III randomized CHHiP trial (CRUK/06/016)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.2-2

2016

Volltextzugriff (PDF)

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom

British journal of radiology, 2015-01, Vol.88 (1056), p.20150453-20150453

2015

Volltextzugriff (PDF)

A multicentre study of the evidence for customized margins in photon breast boost radiotherapy

British journal of radiology, 2016-01, Vol.89 (1058), p.20150603-20150603

2016

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(31)
Buchkapitel
(2)

Sprache

Englisch
(33)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(15)
Oncology
(13)
Radiology, Nuclear Medicine & Medical Imaging
(13)
Middle Aged
(10)
Aged
(9)
Aged, 80 And Over
(8)
Female
(8)
Male
(8)
Hematology, Oncology And Palliative Medicine
(7)
Radiotherapy Dosage
(7)
Treatment Outcome
(6)
Brachytherapy
(5)
Breast Neoplasms - Radiotherapy
(5)
Neoplasm Staging
(5)
Patients
(5)
Prostatic Neoplasms - Radiotherapy
(5)
Radiology And Nuclear Medicine
(5)
Adult
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial

A national dosimetry audit for stereotactic ablative radiotherapy in lung

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial

PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)

1611: Effect of bladder volumes changes on bowel doses during prostate with pelvic lymph-node radiotherapy

Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas

Planning With Intensity-Modulated Radiotherapy and Tomotherapy to Modulate Dose Across Breast to Reflect Recurrence Risk (IMPORT High Trial)

CTNI-70. RADIOTHERAPY QUALITY ASSURANCE IN THE ROAM/EORTC1308 ATYPICAL MENINGIOMA RANDOMISED CONTROLLED TRIAL: PROSPECTIVE REVIEW IMPROVES RADIOTHERAPY QUALITY AND CONSISTENCY

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

BIOPROP20: biologically optimised IMRT for prostate radiotherapy in 20 fractions. Hypofractionated radiotherapy with intraprostatic boosts to tumour nodules in men with intermediate- and high-risk prostate cancer: a phase II trial – five-year outcomes

PIVOTALboost Trial contouring RTQA

The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma

Pretrial outlining quality assurance in PIVITOLBoost

Normal Tissue Complication Probability (NTCP) model for erectile dysfunction (ED) following external beam radiotherapy (RT) for prostate cancer

Local tumor control after 106Ru brachytherapy of choroidal melanoma

Local tumor control after {sup 106}Ru brachytherapy of choroidal melanoma

Forward and inverse-planned intensity-modulated radiotherapy (IMRT) in the CHHiP trial: A comparison of dosimetry and normal tissue toxicity

Visual acuity after Ruthenium106 brachytherapy of choroidal melanomas

Comparison of hypofractionated high-dose intensity-modulated radiotherapy schedules for prostate cancer: Results from the phase III randomized CHHiP trial (CRUK/06/016)

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom

A multicentre study of the evidence for customized margins in photon breast boost radiotherapy

Suchergebnisse filtern